Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.
- DOI
- 10.2174/0113816128498395261019115044
- Published
- 2026 Oct 22
- Container
- Current pharmaceutical design
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0113816128498395261019115044,
title = {Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.},
author = {Babar E and Ur Rehman A and Gul P and Arshad MS and Shah BA and Ahmed N},
year = {2026},
journal = {Current pharmaceutical design},
doi = {10.2174/0113816128498395261019115044},
url = {https://doi.org/10.2174/0113816128498395261019115044}
}RIS
TY - JOUR TI - Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review. AU - Babar E AU - Ur Rehman A AU - Gul P AU - Arshad MS AU - Shah BA AU - Ahmed N PY - 2026 JO - Current pharmaceutical design DO - 10.2174/0113816128498395261019115044 UR - https://doi.org/10.2174/0113816128498395261019115044 ER -
APA
E, B., A, U. R., P, G., MS, A., BA, S., & N, A. (2026). Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review.. Current pharmaceutical design. https://doi.org/10.2174/0113816128498395261019115044
Source records
- pubmed · retrieved 2026-11-10T18:56:18.970Z